Company intelligence / Profile preview

ViridisChem

San Jose, California, United Statesviridischem.com ↗

Ownership: Private
Employees: ~3
Development stage: Commercial

Overview

ViridisChem offers an AI-powered SaaS platform and database for comprehensive toxicity evaluation of chemicals, formulations, and processes. The tools support sustainable product development by providing GHS scores, regulatory information, impurity profiling, NMR/metabolism predictions, and machine-learning-driven toxicity scores. The company’s solutions are used to identify safer alternatives during R&D and process optimization in the life sciences sector. Recognized globally for innovation in green chemistry by UNEP and LAUNCH.org. No clinical results as it does not develop drugs.

Industry: Drug Discovery Services

Partnerships

Plug and Play startup accelerator program participant

Beyond the preview

Go deeper on ViridisChem.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ViridisChem.

Explore the full profile